Reaction

Slow Speech reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,370 reports · 73 co-occurring drugs

As of the last recalculation, Slow Speech appears in 2,370 FAERS reports alongside 73 co-occurring drug terms. The strongest observed disproportionality signal is CENOBAMATE (PRR 26.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Cenobamate	25	26.6	26.7
Cariprazine	15	14.2	14.3
Rasagiline Mesylate	17	13.5	13.5
Pimavanserin Tartrate	77	12.6	12.6
Amitriptyline Hydrochloride	22	11.1	11.1
Quetiapine Fumarate	35	10.6	10.6
Amphetamine	9	9.6	9.6
Donepezil Hydrochloride	38	9.2	9.2
Clobazam	25	9.1	9.1
Carbamazepine	65	8.7	8.7
Amantadine	15	8.6	8.6
Thiamine Hydrochloride	12	8.5	8.5
Lithium	24	8.4	8.4
Lithium Bromatum	24	8.4	8.4
Carbidopa And Levodopa	44	8.3	8.3
Modafinil	29	8.0	8.0
Aripiprazole Oral	37	8.0	8.0
Aripiprazole Orally Disintegrating	37	8.0	8.0
Senna Leaf	20	7.7	7.7
Melatonin	46	7.5	7.6
Valbenazine	21	7.4	7.4
Vortioxetine	14	7.3	7.3
Sennosides 8.6 Mg Tablets	17	7.2	7.2
Senna	17	7.1	7.1
Memantine	11	7.1	7.1
Memantine Hydrochloride	11	7.1	7.1
Mirtazapine	71	7.0	7.0
Lamotirigine	55	6.9	6.9
Lamotrigine Extended-Release	55	6.9	6.9
Lamotrigine Chewable Dispersible	55	6.9	6.9
Bupropion	34	6.8	6.8
Quetiapine	139	6.7	6.7
Haloperidol	18	6.5	6.6
Haloperidol Lactate	18	6.4	6.4
Olanzapine	74	6.2	6.2
Topiramate	63	6.1	6.1
Lacosamide	25	6.0	6.0
Sumatriptan Succinate	17	5.9	5.9
Paliperidone	15	5.7	5.7
Rivastigmine	12	5.6	5.6
Axicabtagene Ciloleucel	6	5.4	5.4
Ethyl Alcohol	16	5.2	5.2
Levetiracetam	77	5.2	5.2
Diroximel Fumarate	7	5.2	5.2
Selinexor	5	5.1	5.1
Botulinum Toxin Type A	7	5.0	5.0
Rotigotine	8	4.9	4.9
Mirabegron	21	4.8	4.8
Cannabidiol	12	4.5	4.5
Buprenorphine Hydrochloride, Naloxone Hydrochloride	12	4.4	4.4
Blinatumomab	5	4.2	4.2
Isopropyl Alcohol	16	4.2	4.2
Alcohol	17	3.9	3.9
Regorafenib	5	3.8	3.8
Lurasidone Hydrochloride	9	3.8	3.8
Ofatumumab	14	3.7	3.7
Teriflunomide	19	3.7	3.7
Paliperidone Palmitate	13	3.6	3.6
Esketamine Hydrochloride	7	3.5	3.5
Droxidopa	8	3.3	3.3
Brexpiprazole	6	3.2	3.2
Fingolimod Hcl	31	3.2	3.2
Dimethyl Fumarate	43	3.1	3.1
Naltrexone Hydrochloride And Bupropion Hydrochloride	3	3.1	3.1
Benralizumab	7	3.1	3.1
Ranibizumab	9	3.0	3.0
Dalfampridine	24	3.0	3.0
Rimegepant Sulfate	4	2.8	2.8
Peginterferon Beta-1A	4	2.7	2.7
Enzalutamide	17	2.6	2.6
Aflibercept	9	2.5	2.5
Natalizumab	45	2.2	2.2
Tapentadol Hydrochloride	7	1.8	1.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.